Cargando…
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis
BACKGROUND: In spite of major advances in treatment, multiple myeloma (MM) is currently an incurable malignancy due to the emergence of drug-resistant clones. We previously showed that MM cells upregulate the transcriptional repressor, growth factor independence 1 (Gfi1), in bone marrow stromal cell...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172782/ https://www.ncbi.nlm.nih.gov/pubmed/30286780 http://dx.doi.org/10.1186/s13045-018-0666-5 |
_version_ | 1783361009407229952 |
---|---|
author | Petrusca, Daniela N Toscani, Denise Wang, Feng-Ming Park, Cheolkyu Crean, Colin D Anderson, Judith L Marino, Silvia Mohammad, Khalid S Zhou, Dan Silbermann, Rebecca Sun, Quanhong Kurihara, Noriyoshi Galson, Deborah L Giuliani, Nicola Roodman, G David |
author_facet | Petrusca, Daniela N Toscani, Denise Wang, Feng-Ming Park, Cheolkyu Crean, Colin D Anderson, Judith L Marino, Silvia Mohammad, Khalid S Zhou, Dan Silbermann, Rebecca Sun, Quanhong Kurihara, Noriyoshi Galson, Deborah L Giuliani, Nicola Roodman, G David |
author_sort | Petrusca, Daniela N |
collection | PubMed |
description | BACKGROUND: In spite of major advances in treatment, multiple myeloma (MM) is currently an incurable malignancy due to the emergence of drug-resistant clones. We previously showed that MM cells upregulate the transcriptional repressor, growth factor independence 1 (Gfi1), in bone marrow stromal cells (BMSCs) that induces prolonged inhibition of osteoblast differentiation. However, the role of Gfi1 in MM cells is unknown. METHODS: Human primary CD138+ and BMSC were purified from normal donors and MM patients’ bone marrow aspirates. Gfi1 knockdown and overexpressing cells were generated by lentiviral-mediated shRNA. Proliferation/apoptosis studies were done by flow cytometry, and protein levels were determined by Western blot and/or immunohistochemistry. An experimental MM mouse model was generated to investigate the effects of MM cells overexpressing Gfi1 on tumor burden and osteolysis in vivo. RESULTS: We found that Gfi1 expression is increased in patient’s MM cells and MM cell lines and was further increased by co-culture with BMSC, IL-6, and sphingosine-1-phosphate. Modulation of Gfi1 in MM cells had major effects on their survival and growth. Knockdown of Gfi1 induced apoptosis in p53-wt, p53-mutant, and p53-deficient MM cells, while Gfi1 overexpression enhanced MM cell growth and protected MM cells from bortezomib-induced cell death. Gfi1 enhanced cell survival of p53-wt MM cells by binding to p53, thereby blocking binding to the promoters of the pro-apoptotic BAX and NOXA genes. Further, Gfi1-p53 binding could be blocked by HDAC inhibitors. Importantly, inoculation of MM cells overexpressing Gfi1 in mice induced increased bone destruction, increased osteoclast number and size, and enhanced tumor growth. CONCLUSIONS: These results support that Gfi1 plays a key role in MM tumor growth, survival, and bone destruction and contributes to bortezomib resistance, suggesting that Gfi1 may be a novel therapeutic target for MM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-018-0666-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6172782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61727822018-10-15 Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis Petrusca, Daniela N Toscani, Denise Wang, Feng-Ming Park, Cheolkyu Crean, Colin D Anderson, Judith L Marino, Silvia Mohammad, Khalid S Zhou, Dan Silbermann, Rebecca Sun, Quanhong Kurihara, Noriyoshi Galson, Deborah L Giuliani, Nicola Roodman, G David J Hematol Oncol Research BACKGROUND: In spite of major advances in treatment, multiple myeloma (MM) is currently an incurable malignancy due to the emergence of drug-resistant clones. We previously showed that MM cells upregulate the transcriptional repressor, growth factor independence 1 (Gfi1), in bone marrow stromal cells (BMSCs) that induces prolonged inhibition of osteoblast differentiation. However, the role of Gfi1 in MM cells is unknown. METHODS: Human primary CD138+ and BMSC were purified from normal donors and MM patients’ bone marrow aspirates. Gfi1 knockdown and overexpressing cells were generated by lentiviral-mediated shRNA. Proliferation/apoptosis studies were done by flow cytometry, and protein levels were determined by Western blot and/or immunohistochemistry. An experimental MM mouse model was generated to investigate the effects of MM cells overexpressing Gfi1 on tumor burden and osteolysis in vivo. RESULTS: We found that Gfi1 expression is increased in patient’s MM cells and MM cell lines and was further increased by co-culture with BMSC, IL-6, and sphingosine-1-phosphate. Modulation of Gfi1 in MM cells had major effects on their survival and growth. Knockdown of Gfi1 induced apoptosis in p53-wt, p53-mutant, and p53-deficient MM cells, while Gfi1 overexpression enhanced MM cell growth and protected MM cells from bortezomib-induced cell death. Gfi1 enhanced cell survival of p53-wt MM cells by binding to p53, thereby blocking binding to the promoters of the pro-apoptotic BAX and NOXA genes. Further, Gfi1-p53 binding could be blocked by HDAC inhibitors. Importantly, inoculation of MM cells overexpressing Gfi1 in mice induced increased bone destruction, increased osteoclast number and size, and enhanced tumor growth. CONCLUSIONS: These results support that Gfi1 plays a key role in MM tumor growth, survival, and bone destruction and contributes to bortezomib resistance, suggesting that Gfi1 may be a novel therapeutic target for MM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-018-0666-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-04 /pmc/articles/PMC6172782/ /pubmed/30286780 http://dx.doi.org/10.1186/s13045-018-0666-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Petrusca, Daniela N Toscani, Denise Wang, Feng-Ming Park, Cheolkyu Crean, Colin D Anderson, Judith L Marino, Silvia Mohammad, Khalid S Zhou, Dan Silbermann, Rebecca Sun, Quanhong Kurihara, Noriyoshi Galson, Deborah L Giuliani, Nicola Roodman, G David Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
title | Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
title_full | Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
title_fullStr | Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
title_full_unstemmed | Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
title_short | Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
title_sort | growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172782/ https://www.ncbi.nlm.nih.gov/pubmed/30286780 http://dx.doi.org/10.1186/s13045-018-0666-5 |
work_keys_str_mv | AT petruscadanielan growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT toscanidenise growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT wangfengming growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT parkcheolkyu growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT creancolind growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT andersonjudithl growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT marinosilvia growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT mohammadkhalids growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT zhoudan growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT silbermannrebecca growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT sunquanhong growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT kuriharanoriyoshi growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT galsondeborahl growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT giulianinicola growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis AT roodmangdavid growthfactorindependence1expressioninmyelomacellsenhancestheirgrowthsurvivalandosteoclastogenesis |